Logiscreen

Novo Nordisk

$42.96
Market Cap 191.82B
ROE 66.4%
Gross Margin 86.0%
Debt/Equity 0.7
Current Ratio 0.8
Revenue QoQ 24.0%
EPS QoQ 0.7%
F-Score 6

About

Novo Nordisk is a leading global health care company that's been making innovative medicines to help people with diabetes lead longer, healthier lives for more than 100 years. This heritage has given us experience and capabilities that also enable us to drive change to help people defeat other serious chronic diseases such as obesity, rare blood, and endocrine disorders. We remain steadfast in our conviction that the formula for lasting success is to stay focused, think long-term, and do business in a financially, socially, and environmentally responsible way.

Exchange
NYSE
Sector
Healthcare
Industry
Biotechnology

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
10.31
vs median 33.61
P/B
6.19
vs median 2.16
ROE
0.66
vs median 0.09

Decent quality with acceptable fundamentals

Large-cap company with established market presence

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics